News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.

Life sciences investors share tips on raising funds and conserving cash in a tight market
At the annual Life Science Innovation Northwest conference, life science funding and investment experts joined to discuss the current funding landscape in the “Finance: Defining

Lab software company Genemod raises $4.5M seed round
Genemod, a Seattle-based lab software startup, raised $4.5 million in a seed funding round. The company’s cloud-based platform helps life sciences companies and researchers manage

Evergreen Bioscience envisions new bioscience building, sets sights on larger goals
The Evergreen Bioscience Innovation Cluster is taking the first steps to develop a new facility costing up to $50 million and providing space for up

Report: Life Science Washington outlines sector’s growth during pandemic
In 2021 Washington’s life science industry employed 43,546 workers and had an economic impact of $35.5 billion, according to the latest Economic Impact Report from

Report details economic impact of Washington life science industry
The latest Economic Impact Report by the trade association Life Science Washington shows that the Washington life science industry supports more than 100,000 jobs statewide

GeekWire Awards: How this Ukrainian-born CEO created a biotech startup ‘where curious scientists thrive’
Seattle-based biotech Phase Genomics founder Ivan Liachko didn’t plan on founding a company. After discovering techniques revealing how DNA is organized inside a cell and

40 Under 40: Kayla Garrett, Bristol Myers Squibb
Bristol Myers Squibb Senior Scientist Kayla Garrett is a Puget Sound Business Journal 40 under 40 honoree. She has worked towards a new approach to

Powerful protein design software harnesses board game-playing AI
An international research team led by the University of Washington scientists has successfully applied reinforcement learning, a type of machine learning where a computer program

Report highlights growth of life sciences sector in Seattle, buoyed by NIH funding
According to CBRE’s new life sciences outlook report, Seattle life sciences employment and National Institutes of Health (NIH) funding have experienced rapid growth since 2019.

Omeros lands $6.7M grant to test treatment for cocaine addiction
Seattle-based biotech Omeros received a $6.7 million grant from the National Institute on Drug Abuse to test the company’s cocaine treatment drug candidate OMS527 in

CBRE: Seattle life sciences market stays resilient amidst headwinds
A new report from CBRE revealed that, despite the current economic state, the life science industry’s demand for lab space is still above pre-pandemic levels

Biologists say deep learning is revolutionizing pace of innovation
Artificial intelligence has advanced many operations and is even finding ways to revolutionize biology innovations that will accelerate drug discovery and other advances in life
